Oppenheimer Reiterates Outperform on Achieve Life Sciences, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Francois Brisebois has reiterated an Outperform rating on Achieve Life Sciences (NASDAQ:ACHV) and maintained a price target of $11.
August 15, 2024 | 1:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Francois Brisebois has reiterated an Outperform rating on Achieve Life Sciences (NASDAQ:ACHV) and maintained a price target of $11.
The reiteration of an Outperform rating and the maintenance of a price target at $11 by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100